2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

報告編號：1335036 ┊ 產業調研網 CIR.cn ┊ 推薦：

名　稱：2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry
編　號：1335036　
市場價：電子版18500元　　紙質+電子版19000元
優惠價：電子版16650元　　紙質+電子版16950元
電　話：400 612 8668、010-6618 1099、66182099、66183099
郵　箱：KF@Cir.cn　　《訂購協議》下載
提　示：如需中文、日文等其他語言版本，請與我們聯系。
網上訂購　　下載訂購協議　　 Pdf格式下載

2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

字號：大中小報告內容：

"2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry" was professional and depth research report on China Synthesis Polypeptide Drug industry. The report firstly introduced Synthesis Polypeptide Drug basic information included Synthesis Polypeptide Drug definition classification application industry chain structure industry overview； international market analysis， China domestic market analysis， Macroeconomic environment and economic situation analysis and influence， Synthesis Polypeptide Drug industry policy and plan， Synthesis Polypeptide Drug product specification， manufacturing process， product cost structure etc. then statistics China key manufacturers Synthesis Polypeptide Drug capacity production cost price profit production value gross margin etc details information， at the same time， statistics these manufacturers Synthesis Polypeptide Drug products customers application capacity market position company contact information etc company related information， then collect all these manufacturers data and listed China Synthesis Polypeptide Drug capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics， and then introduced China Synthesis Polypeptide Drug 2009-2014 capacity production price cost profit production value gross margin etc information. And also listed Synthesis Polypeptide Drug upstream raw materials equipments and Sharp Solarnstream clients alternative products survey analysis and Synthesis Polypeptide Drug marketing channels industry development trend and proposals. In the end， this report introduced Synthesis Polypeptide Drug new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis of China Synthesis Polypeptide Drug industry. In a word， it was a depth research report on China Synthesis Polypeptide Drug industry. And thanks to the support and assistance from Synthesis Polypeptide Drug industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Chapter One Synthesis Polypeptide Drug Industry Overview
1.1 Synthesis Polypeptide Drug Definition
1.2 Synthesis Polypeptide Drug Classification and Application
1.3 Professional Terms Interpretation
1.4 Synthesis Polypeptide Drug Industry Chain Structure
1.5 Synthesis Polypeptide Drug Industry Overview

Chapter Two Synthesis Polypeptide Drug International and China Market Analysis
2.1 Synthesis Polypeptide Drug Industry International Market Analysis
2.1.1 Synthesis Polypeptide Drug International Market Development History
2.1.2 Synthesis Polypeptide Drug Product and Technology Developments
2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis
2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status
2.1.5 Synthesis Polypeptide Drug International Market Development Trend
2.2 Synthesis Polypeptide Drug China Market Analysis
2.2.1 Synthesis Polypeptide Drug China Market Development History
2.2.2 Synthesis Polypeptide Drug Product and Technology Developments
2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis
2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status
2.2.5 Synthesis Polypeptide Drug China Market Development Trend
2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis

Chapter Three Major Synthesis Polypeptide Drug Analysis
3.1 Immunity Regulating Medicine （Allergy Infection and Immune）
3.1.1 Glatiramer Injection （Glatiramer Acetate）
3.1.2 Thymalfasin for Injection
3.1.3 Thymopentin Injection
3.1.4 Thymopetidum Injection
3.1.5 Summary
3.2 Digestive System Drugs （Gastrointestinal Type）
3.2.1 Octreotide Acetate Injection
3.2.2 Somatostatin for Injection
3.3 Bone and Connective Tissue Types （Thyroid hormones Drug）
3.3.1 Salmon Calcitonin Injection
3.3.2 Elcatonin Injection
3.3.4 TerfparaLide Injectlon
3.4 Gynecologic or Obstetric Drug
3.4.1 Oxytocin Injection
3.4.2 Carbetocin Injection
3.4.3 Acetate Atosiban Injection
全.文：http://www.5269660.cn/2014-01/Deep_Research_Report_on_Global_and_China_Synthesis_Polypeptide_Drug_Industry/
3.5 Tumor Drug （hCG）
3.5.1 Leuprorelin Acetate Microspheres for Injection
3.5.2 Goserelin Acetate
3.5.3 Triptorelin Acetate Injection
3.5.4 Chorionic Gonadotrophin for Injection
3.6 Urinary System Drug （Diabetes Insipidus）
3.6.1 Desmopressin Acetate Injection
3.6.2 Terlipressin for Injection
3.7 Metabolic Drug （Insulin and Other Hypoglycemic Agents）
3.7.1 Biosynthetic Glucagon for Injection
3.7.2 Exenatide Injection

Chapter Four Synthesis Polypeptide Drug Industry Development Environmental Analysis
4.1 China Economic Environment Analysis
4.1.1 China GDP Analysis
4.1.2 China CPI Analysis
4.2 European Economic Environmental Analysis
4.3 United States Economic Environmental Analysis
4.4 Japan Economic Environmental Analysis
4.5 Global Economic Environmental Analysis

Chapter Five Synthesis Polypeptide Drug Development Policy and Plan
5.1 China Government Policy and Development Plan
5.2 Industry Policy and Standard
5.3 Technical Standard
5.4 Technology Replacement and R&D Trends
5.5 Hotspots and Influence

Chapter Six Synthesis Polypeptide Drug Manufacturing Process and Cost Structure
6.1 Synthesis Polypeptide Drug Manufacturing Process Overview
6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis
6.3 Synthesis Polypeptide Drug Cost Structure Analysis

Chapter Seven 2009-2014 Synthesis Polypeptide Drug Productions Supply Sales Demand Market Status and Forecast
7.1 2009-2014 Synthesis Polypeptide Drug Capacity Production Overview
7.1.1 2009-2014 Global and China Synthesis Polypeptide Drug Capacity Production
7.1.2 2009-2014 Synthesis Polypeptide Drug Production Market Share
7.1.3 2009-2014 Synthesis Polypeptide Drug Demand Overview
7.1.4 2009-2014 Synthesis Polypeptide Drug Supply Demand and Shortage
7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis
7.2.1 Thymopentin Injection
7.2.2 Thymalfasin Injection
7.2.3 Calcitonin Injection
7.2.4 Somatostatin for Injection
7.2.5 Octreotide Acetate Injection
7.2.6 Desmopressin Acetate Injection
7.3 Synthesis Polypeptide Drug Market Summary

Chapter Eight Synthesis Polypeptide Drug Key Manufacturers
8.1 Novartis
8.2 Merck Serono
8.3 Ferring Pharmaceuticals
8.4 Ipsen PHarma Biotech
8.5 Lilly
8.6 Asahi Kasei
8.7 AstraZeneca
8.8 SciClone Pharmaceuticals
8.9 Takeda
8.10 HYBIO Pharmaceutical Co.，Ltd （Shenzhen Stock：300199）
8.11 Hainan Zhonghe Pharmaceutical Co.，Ltd
8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd
8.13 Beijing Yingu Century Pharmaceutical Co.，Ltd （Beijing Shiqiao Bio-Pharmaceutical Co.，Ltd）
8.14 Hainan Shuangcheng Pharmaceuticals Co.，Ltd
8.15 Livzon Pharmaceuticals Co.，Ltd （Livzon：000513）
8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd
8.17 Chengdu Tiantaishan Pharmaceutical Co.，Ltd
8.18 Beijing Shuanglu Pharmaceutical Co.，Ltd
8.19 Yangzijiang Pharmaceutical Co.，Ltd
8.20 Changzhou Siyao Pharmaceutical Co.，Ltd

Chapter Nine Up and Down Stream Industry Analysis and Influence
9.1 Upstream Raw Materials Price Analysis and Influence
9.1 Upstream Equipments Market Analysis and Influence
9.3 Downstream Demand Analysis and Influence
9.4 Industry Policy Analysis and Influence

Chapter Ten Synthesis Polypeptide Drug Marketing Channels Analysis
10.1 Synthesis Polypeptide Drug Marketing Channels Status
10.1.1 Drugs Marketing Channel Developemnt History
10.1.1 Prescription Drug Marketing Development Status
10.2 Synthesis Polypeptide Drug Marketing Channels Management
10.3 Synthesis Polypeptide Drug Marketing Channels Establishment
10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend
11.1 2014-2019 Synthesis Polypeptide Drug Industry Development Trend
11.2 2014-2019 Market Potential Forecast
2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry
11.3 2014-2019 R&D Trend
11.3.1 Polypeptide Drug Technical Development Status
11.3.2 Polypeptide Drug and Health Care Products Research and Manufacturing Overview
11.3.3 China Polypeptide Drug Development Direction and Prospect
11.4 2014-2019 Marketing Channels Change Trend
14.4.1 Prescription Drug Marketing Channels Change Trend
14.4.2 Prescription Drug Sales Method Five Trend

Chapter Twelve Synthesis Polypeptide Drug Industry Development Proposals
12.1 Macroeconomic Development Countermeasures
12.2.1 New Business Entry Barriers
12.2.2 New Corporate Strategy
12.3 New Project Investment Proposal
12.4 Marketing Channel Strategy Proposals
12.5 Competitive Environment Strategy Proposals
12.5.1 Competitive Environment Analysis
12.5.2 Strategy Proposals

Chapter Thirteen Synthesis Polypeptide Drug New Project Investment Feasibility Analysis
13.1 Synthesis Polypeptide Drug Project SWOT Analysis
13.2 Synthesis Polypeptide Drug New Project Investment Feasibility Analysis
13.2.1 Buildings
13.2.2 Investment
13.2.3 Project Schedule
13.2.4 Project Investment Return and Feasibility Analysis

Chapter Fourteen Synthesis Polypeptide Drug Industry Research Conclusions
Tables and Figures
Figure Synthesis Polypeptide Process Flow
Figure Synthesis Polypeptide Drug Picture-Thymopentin Injection
Figure Polypeptide Applications on Health Care Food and Cosmetics Fields
Figure Polypeptide Drug Manufacturing Process Method
Table Synthesis Polypeptide Drug Classification and Application List
Table Synthesis Polypeptide Drug Product Name Use and Annual Sales Revenue （USD） List
Table Listed Polypeptide Drug Name Type Indication
Figure Pharmaceutical Industry Value Chain Structure
Figure Pharmaceutical Industry Industry Chain Structure
Figure Synthesis Polypeptide Drug Industry Chain Structure
Figure Synthesis Polypeptide Drug Industrialization System
Figure 2000-2013 China Pharmaceutical Industry Sales Revenue and Total Profit （100 Million RMB） and Growth Rate
Figure 2007-2015 China Synthesis Polypeptide Drug Market Scale （100 Million RMB） and Growth Rate
Figure DNA Transcribed into RNA Diagram
Figure RNA Translated into Polypeptide Chains Molecular Diagram
Table Polypeptide Drug Three Manufacturing Methods
Figure 1984 Chemistry Nobel Prize Winner Robert Bruce Merrifield
Figure Polypeptide Solid Phase Synthesis Principle
Figure Solid Phase Polypeptide Synthesis
Figure United States CS Three Channel Full Automatic Polypeptide Synthetic Instrument
Figure Homemade CS136 Model Research Polypeptide Synthetic Instrument
Figure Large Scale Liquid Phase Synthesis of Polypeptide
Figure Thin Film Evaporator （for perishable goods Concentration）
Table Global 2008 Revenue More than 1 Billion Polypeptide Drug Brands List
Table Some Listed Polypeptide Drug Indication Classification
Figure Listed Polypeptide Drug Indication Classification Market Share
Figure 2004-2014 Global Pharmaceutical Sales Revenue （Billion USD） and Growth Rate
Figure 2009-2014 International Synthesis Polypeptide Drug Market Scale （100 Million RMB） and Growth Rate
Table 2013 Some Polypeptide Drug Global Sales Revenue （100 Million USD）
Figure Each Year Enter Clinical Research Polypeptide Drug Quantity （Piece）
Table 17 Emerging Pharmaceutical Market Sizes （Billion USD）
Figure 2007-2015 China Pharmaceutical Sales Revenue （100 Million USD）
Figure 2009-2015 China Polypeptide Drug Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale （100 Million RMB） and Proportion of China Total Polypeptide Drug Market Scale
Figure 2007-2013 China Chemical Synthesis Polypeptide Drug Types Market Share
Table Copaxone Neuron Structure Diagram
Table Thymalfasin for Injection （Thymalfasin a1） Suppliers List
Table 2013 Thymalfasin for Injection Key Products Price （RMB/Piece） List
Table Some Thymopentin Injection Suppliers List
Table Thymopentin Injection Hospital Purchase Price （RMB/Piece） List
Table Leuprorelin Acetate Microspheres for Injection Suppliers Product Specification Price List
Table Octreotide Acetate Injection Key Suppliers List
Table 2013 Hebei Province Octreotide Acetate Injection Bid Price List
Tale Somatostatin for Injection Key Suppliers List
Table Somatostatin for Injection Key Products Hospital Average Purchae Price List
Table 2013 Hebei Province Somatostatin for Injection Key Suppliers List
Table Salmon Calcitonin Injection Suppliers List
Table Salmon Calcitonin Injection/Nasal Spray Products Hospital Purchase Price List
Table Salmon Calcitonin Injection/Nasal spray Products Retail Price List
Table Elcatonin Injection Key Suppliers and Product Selling Price List
Figure TerfparaLide Injectlon—Forsteo Injection Pen Parts
Table 2014Q1 China Some Aproved New Drug Number， Specifications Suppliers and Indication
2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry
Table 2013 New Add Key Monitoring Drug Table--TerfparaLide Injectlon
able Carbetocin Injection Suppliers List
Table Acetate Atosiban Injection Supplier Product Specification Price List
Table Leuprorelin Acetate Microspheres for Injection Suppliers Product Specification Price List
Table Oxytocin Injection Key Suppliers List
Table Oxytocin Injection Suppliers Products Models List
Table Triptorelin Acetate Injection Suppliers Product Specification Price List
Table 2013 Some Hormone Drugs Independent Pricing and Uniform Pricing Comparison
Table Desmopressin Acetate Injection Key Suppliers List
Table Desmopressin Acetate Injection Key Suppliers Forms Product Specifications and Bid Price List
Table Terlipressin for Injection Key Brands Manufacturers and Retail Prices
Table Biosynthetic Glucagon for Injection Suppliers and Retail Prices List
Table Exenatide Suppliers Product Specifications Retail Prices List
Figure 2005-2013 China GDP and Growth Rate
Figure 2005-2013 China CPI Change Trend
Figure 2005-2013 China PMI Change Trend
Figure 2005-2012 Financial Revenue （Billion yuan） and Growth
Figure Total Fixed Asset Investment （Billion yuan）
Figure 2005-2013 European GDP Growth Rate
Figure 2006-2013 European CPI Change Trend
Figure 2005-2013 United States GDP Change Trend
Figure 2006-2013 United States CPI Change Trend
Figure 2005-2013 Japan GDP Change Trend
Figure 2006-2013 Japan CPI Change Trend
Figure 2009-2013 China Health Capital Investment （100 Million RMB）
Table China Pharmaceutical Industry All major Departments and Regulatory Functions
Table Pharmaceutical Industry main Laws and Regulations and Policies
Table 2009-2014 China Medical and Health System Reform Important Policy
Table 2009-2014 China Related Pharmaceutical Product Quality Supervision Policy
Table 2009-2014 China Development and Reform Commission Policy on Drug Price Management Policies
Figure PTIPolypeptide Synthetic Instruments Picture
Table Synthesis Polypeptide Drug Technology Processes List
Figure Polypeptide Pharmaceutical Raw Materials Manufacturing Process Flow
Figure Freeze Dried Powder Injection Manufacturing Process Flow
Figure Small Capacity Injection Manufacturing Process Flow
Figure Thymalfasin API Manufacturing Process Flow
Figure Thymalfasin Injection Manufacturing Process Flow
Figure International Synthesis Polypeptide Drug Cost Structure
Table 2009-2014 China Synthesis Polypeptide Drug Cost Structure
Table 2009-2014 Global Key Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity （10K Piece） List
Table 2009-2014 Global Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share List
Table 2009-2014 Global Key Manufacturers Synthesis Polypeptide Drug Production and Total Production （10K Piece） List
Table 2009-2014 Global Key Manufacturers Synthesis Polypeptide Drug Production Market Share List
Table 2009-2014 China Key Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity （10K Piece） List
Table 2009-2014 China Key Manufacturers Synthesis Polypeptide Drug Capacity Market Share List
Table 2009-2014 China Key Manufacturers Synthesis Polypeptide Drug Production and Total Production （10K Piece） List
Table 2009-2014 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share List
Figure 2009-2014 Global Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table 2009-2014 Global Synthesis Polypeptide Drug Capacity Utilization Rate List
Figure 2009-2014 China Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table 2009-2014 China Synthesis Polypeptide Drug Capacity Utilization Rate List
Table 2009-2014 Key Manufacturers Synthesis Polypeptide Drug China Sales （10K Piece） Top20 List
Table 2009-2014 Key Manufacturers Synthesis Polypeptide Drug China Sales Top20 Market Share List
Table 2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue （100 Million RMB） Top10 List
Table 2008-2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue Top10 Market Share List
Figure 2011 Key Manufacturers Synthesis Polypeptide Drug China Sales Market Share
Figure 2012 Key Manufacturers Synthesis Polypeptide Drug China Sales TOP20 Market Share
Figure 2011 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share
Figure 2012 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share
Table 2009-2014 Global Synthesis Polypeptide Drug Demand （10K Piece） and Growth Rate
Table 2009-2014 China Synthesis Polypeptide Drug Demand （10K Piece） and Growth Rate
Table 2009-2014 China Synthesis Polypeptide Drug Supply Demand and Shortage （10K Piece）
Table 2009-2014 Nine Foreign Enterprises Synthesis Polypeptide Drug China Sales （10K Piece） List
Table 2009-2014 China Synthesis Polypeptide Drug Production Import Export Consumption （10K Piece） List
Table 2009-2014 China Synthesis Polypeptide Drug Price （RMB/Piece） Distribution
Table 2009-2014 Hainan Shuangcheng Pharmaceuticals Some Synthesis Polypeptide Drug Price Cost （RMB/Piece） Gross Margin List
Table 2009-2014 China Synthesis Polypeptide DrugProduction （10K Piece） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2013 China Synthesis Polypeptide Drug Market Share by Different Type Drug
Figure 2009-2014 China Thymopentin Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Thymopentin Injection Sales （10K Piece） and Growth Rate
Figure 2009-2014 China Thymalfasin Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Thymalfasin Injection Sales （10K Piece） and Growth Rate
Figure 2009-2014 China Calcitonin Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Calcitonin Injection Sales （10K Piece） and Growth Rate
Figure 2009-2014 China Somatostatin for Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Somatostatin for Injection Sales （10K Piece） and Growth Rate
Figure 2009-2014 China Octreotide Acetate Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Octreotide Acetate Injection Sales （10K Piece） and Growth Rate
2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry
Figure 2009-2014 China Desmopressin Acetate Injection Market Scale （100 Million RMB） and Growth Rate
Figure 2009-2014 China Desmopressin Acetate Injection Sales （10K Piece） and Growth Rate
Table 2009-2014 China Chemical Synthesis Polypeptide Drug Injection Distribution List
Figure 2013 Global Polypeptide Drug Market Structure by Treatment Class
Table Research or Listed Polypeptide Drugs List
Figure 1990-2013 China Resident Three Types of Chronic Disease Prevalence （1/100K） Change Trend
Figure 2013 China Synthesis Polypeptide Drug Hospital Terminal Sales Market Share Distribution
Figure 2013 China Synthesis Polypeptide Drug Top10 Manufacturers Sales Revenue （100 Million RMB）
Figure China Synthesis Polypeptide Drug Prices Distribution
Figure Use Me-Too Model Developed Polypeptide Drug List
Table Novartis Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Novartis China Market Sales Synthesis Polypeptide Drug--Octreotide Acetate Injection
Figure Novartis China Market Sales Synthesis Polypeptide Drug--Somatostatin Acetate for Injection
Figure Novartis China Market Sales Synthesis Polypeptide Drug--salmon Calcitonin Nasal Spray
Table 2009-2014 Novartis Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Novartis Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Merck Serono Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Merck Serono Synthesis Polypeptide Drug--Recombinant Human Follitropin Alfa Solution for Injection
Figure Merck Serono Synthesis Polypeptide Drug--Somatostatin for Injection
Figure Merck Serono Synthesis Polypeptide Drug--Gonadorelin for Injection
Table 2009-2014 Merck Serono Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Merck Serono Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Ferring Pharmaceuticals Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Minirin
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Decapeptyl
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Pentasa
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Glypressin
Figure Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug--Octostim
Table 2009-2014 Ferring Pharmaceuticals Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Ferring Pharmaceuticals Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Ipsen PHarma Biotech Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Ipsen PHarma Biotech Synthesis Polypeptide Drug--Triptorelin Acetate for Injection
Table 2009-2014 Ipsen PHarma Biotech Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Ipsen PHarma Biotech Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Lilly Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Lilly Some China Listed Synthesis Polypeptide Drug List
Table 2009-2014 Lilly Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Lilly Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Asahi Kasei Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Asahi Kasei Synthesis Polypeptide Drug--Elcatonin Injection
Table 2009-2014 Asahi Kasei Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Asahi Kasei Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table AstraZeneca Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure AstraZeneca China Selling Synthesis Polypeptide Drug—Goserelin Acetate Slow Release Implantation Agent
Table 2009-2014 Jiangsu AstraZeneca Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Jiangsu AstraZeneca Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table SciClone Pharmaceuticals Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure SciClone Pharmaceuticals Synthesis Polypeptide Drug-- Thymopetidum α1 Injection
Table 2009-2014 SciClone Pharmaceuticals Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 SciClone Pharmaceuticals Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Takeda Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Takeda--Leuprorelin Acetate Microspheres for Injection
Table 2009-2014 Takeda Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Takeda Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table HYBIO Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure 2009-2014 HYBIO Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug
Table 2009-2014 HYBIO Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 HYBIO Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Hainan Zhonghe Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Hainan Zhonghe Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Product
Table 2009-2014 Hainan Zhonghe Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Hainan Zhonghe Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd Synthesis Polypeptide Drug—Thymalfasin Injection
Figure Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd Synthesis Polypeptide Drug—Thymopentin Injection
Table 2009-2014 Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Beijing Yingu Century Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Beijing Yingu Century Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Nasal Spray
Figure Beijing Yingu Century Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Thymopentin Injection
Table 2009-2014 Beijing Yingu Century Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Beijing Yingu Century Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Hainan Shuangcheng Pharmaceuticals Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Hainan Shuangcheng Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug--Thymalfasin Injection（Kitai）
Figure Hainan Shuangcheng Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug—Somatostatin for Injection
Figure Hainan Shuangcheng Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug—Thymopentin Injection （Double into a can-dimensional）
Table 2009-2014 Hainan Shuangcheng Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Hainan Shuangcheng Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
グローバルおよび中國の合成ペプチド醫薬品産業に関する2014ディープ研究報告
Table Livzon Pharmaceuticals Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Livzon Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug
Table 2009-2014 Livzon Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Livzon Pharmaceuticals Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug--Thymopentin Injection
Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug--Somatostatin for Injection
Table 2009-2014 Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Chengdu Tiantaishan Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Chengdu Tiantaishan Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug—Somatostatin for Injection
Figure Chengdu Tiantaishan Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug—Thymopentin Injection
Figure Chengdu Tiantaishan Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug—Octreotide Acetate Injection
Table 2009-2014 Chengdu Tiantaishan Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Chengdu Tiantaishan Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Beijing Shuanglu Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Beijing Shuanglu Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Thymopentin Injection
Figure Beijing Shuanglu Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Injection
Table Beijing Shuanglu Pharmaceutical Co.，Ltd Thymopentin Injection Price List
Table 2009-2014 Beijing Shuanglu Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Beijing Shuanglu Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Yangzijiang Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Yangzijiang Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Somatostatin for Injection
Figure Yangzijiang Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug-Thymopentin Injection
Table 2009-2014 Yangzijiang Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Yangzijiang Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Changzhou Siyao Pharmaceutical Co.，Ltd Company Information Table （Products Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information etc 13 Items）
Figure Changzhou Siyao Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug List
Table Changzhou Siyao Pharmaceutical Co.，Ltd Chemical Pharmaceutical Raw Materials List
Table Changzhou Siyao Pharmaceutical Co.，Ltd Chemical Raw Materials Intermediates List
Table 2009-2014 Changzhou Siyao Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Production （10K Piece） Cost Price Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List
Figure 2009-2014 Changzhou Siyao Pharmaceutical Co.，Ltd Synthesis Polypeptide Drug Capacity Production （10K Piece） and Growth Rate
Table Synthesis Polypeptide Drug Project Key Equipments and Price （10K RMB）
Table Synthesis Polypeptide Drug Project Equipments List and Price （10K RMB）
Table Drugs Manufacturing Enterprise Specialized Academic Promotion Organization Frame
Figure Synthesis Polypeptide Drug Industry Entry Barriers List
Table 2013 China Synthesis Polypeptide Drug New Project SWOT Analysis
Table 2013 China Synthesis Polypeptide Drug New Project Buildings List
Table 2013 China Synthesis Polypeptide Drug New Project Investments （10K RMB） List
Table 30Million Pieces/Year Synthesis Polypeptide Drug New Project Investment Return and Feasibility Analysis

　　http://www.5269660.cn/2014-01/Deep_Research_Report_on_Global_and_China_Synthesis_Polypeptide_Drug_Industry/

　　產業調研網

　　……

掃一掃 “2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry”

如需購買《2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry》，編號：1335036
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn　　【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”

2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

訂閱Rss更新 下載電子版產業調研網 > 調研報告 > 其他行業 > 2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

Chapter One Synthesis Polypeptide Drug Industry Overview

1.1 Synthesis Polypeptide Drug Definition

1.2 Synthesis Polypeptide Drug Classification and Application

1.3 Professional Terms Interpretation

1.4 Synthesis Polypeptide Drug Industry Chain Structure

1.5 Synthesis Polypeptide Drug Industry Overview

Chapter Two Synthesis Polypeptide Drug International and China Market Analysis

2.1 Synthesis Polypeptide Drug Industry International Market Analysis

2.2 Synthesis Polypeptide Drug China Market Analysis

2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis

Chapter Three Major Synthesis Polypeptide Drug Analysis

3.1 Immunity Regulating Medicine （Allergy Infection and Immune）

3.2 Digestive System Drugs （Gastrointestinal Type）

3.3 Bone and Connective Tissue Types （Thyroid hormones Drug）

3.4 Gynecologic or Obstetric Drug

3.5 Tumor Drug （hCG）

3.6 Urinary System Drug （Diabetes Insipidus）

3.7 Metabolic Drug （Insulin and Other Hypoglycemic Agents）

Chapter Four Synthesis Polypeptide Drug Industry Development Environmental Analysis

4.1 China Economic Environment Analysis

4.2 European Economic Environmental Analysis

4.3 United States Economic Environmental Analysis

4.4 Japan Economic Environmental Analysis

4.5 Global Economic Environmental Analysis

Chapter Five Synthesis Polypeptide Drug Development Policy and Plan

5.1 China Government Policy and Development Plan

5.2 Industry Policy and Standard

5.3 Technical Standard

5.4 Technology Replacement and R&D Trends

5.5 Hotspots and Influence

Chapter Six Synthesis Polypeptide Drug Manufacturing Process and Cost Structure

6.1 Synthesis Polypeptide Drug Manufacturing Process Overview

6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis

6.3 Synthesis Polypeptide Drug Cost Structure Analysis

Chapter Seven 2009-2014 Synthesis Polypeptide Drug Productions Supply Sales Demand Market Status and Forecast

7.1 2009-2014 Synthesis Polypeptide Drug Capacity Production Overview

7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis

7.3 Synthesis Polypeptide Drug Market Summary

Chapter Eight Synthesis Polypeptide Drug Key Manufacturers

8.1 Novartis

8.2 Merck Serono

8.3 Ferring Pharmaceuticals

8.4 Ipsen PHarma Biotech

8.5 Lilly

8.6 Asahi Kasei

8.7 AstraZeneca

8.8 SciClone Pharmaceuticals

8.9 Takeda

8.10 HYBIO Pharmaceutical Co.，Ltd （Shenzhen Stock：300199）

8.11 Hainan Zhonghe Pharmaceutical Co.，Ltd

8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd

8.13 Beijing Yingu Century Pharmaceutical Co.，Ltd （Beijing Shiqiao Bio-Pharmaceutical Co.，Ltd）

8.14 Hainan Shuangcheng Pharmaceuticals Co.，Ltd

8.15 Livzon Pharmaceuticals Co.，Ltd （Livzon：000513）

8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd

8.17 Chengdu Tiantaishan Pharmaceutical Co.，Ltd

8.18 Beijing Shuanglu Pharmaceutical Co.，Ltd

8.19 Yangzijiang Pharmaceutical Co.，Ltd

8.20 Changzhou Siyao Pharmaceutical Co.，Ltd

Chapter Nine Up and Down Stream Industry Analysis and Influence

9.1 Upstream Raw Materials Price Analysis and Influence

9.1 Upstream Equipments Market Analysis and Influence

9.3 Downstream Demand Analysis and Influence

9.4 Industry Policy Analysis and Influence

Chapter Ten Synthesis Polypeptide Drug Marketing Channels Analysis

10.1 Synthesis Polypeptide Drug Marketing Channels Status

10.2 Synthesis Polypeptide Drug Marketing Channels Management

10.3 Synthesis Polypeptide Drug Marketing Channels Establishment

10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend

11.1 2014-2019 Synthesis Polypeptide Drug Industry Development Trend

11.2 2014-2019 Market Potential Forecast

11.3 2014-2019 R&D Trend

11.4 2014-2019 Marketing Channels Change Trend

Chapter Twelve Synthesis Polypeptide Drug Industry Development Proposals

12.1 Macroeconomic Development Countermeasures

12.3 New Project Investment Proposal

12.4 Marketing Channel Strategy Proposals

訂閱Rss更新下載電子版產業調研網 > 調研報告 > 其他行業 > 2014 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

　1.1 Synthesis Polypeptide Drug Definition

　1.2 Synthesis Polypeptide Drug Classification and Application

　1.3 Professional Terms Interpretation

　1.4 Synthesis Polypeptide Drug Industry Chain Structure

　1.5 Synthesis Polypeptide Drug Industry Overview

　2.1 Synthesis Polypeptide Drug Industry International Market Analysis

　2.2 Synthesis Polypeptide Drug China Market Analysis

　2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis

　3.1 Immunity Regulating Medicine （Allergy Infection and Immune）

　3.2 Digestive System Drugs （Gastrointestinal Type）

　3.3 Bone and Connective Tissue Types （Thyroid hormones Drug）

　3.4 Gynecologic or Obstetric Drug

　3.5 Tumor Drug （hCG）

　3.6 Urinary System Drug （Diabetes Insipidus）

　3.7 Metabolic Drug （Insulin and Other Hypoglycemic Agents）

　4.1 China Economic Environment Analysis

　4.2 European Economic Environmental Analysis

　4.3 United States Economic Environmental Analysis

　4.4 Japan Economic Environmental Analysis

　4.5 Global Economic Environmental Analysis

　5.1 China Government Policy and Development Plan

　5.2 Industry Policy and Standard

　5.3 Technical Standard

　5.4 Technology Replacement and R&D Trends

　5.5 Hotspots and Influence

　6.1 Synthesis Polypeptide Drug Manufacturing Process Overview

　6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis

　6.3 Synthesis Polypeptide Drug Cost Structure Analysis

　7.1 2009-2014 Synthesis Polypeptide Drug Capacity Production Overview

　7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis

　7.3 Synthesis Polypeptide Drug Market Summary

　8.1 Novartis

　8.2 Merck Serono

　8.3 Ferring Pharmaceuticals

　8.4 Ipsen PHarma Biotech

　8.5 Lilly

　8.6 Asahi Kasei

　8.7 AstraZeneca

　8.8 SciClone Pharmaceuticals

　8.9 Takeda

　8.10 HYBIO Pharmaceutical Co.，Ltd （Shenzhen Stock：300199）

　8.11 Hainan Zhonghe Pharmaceutical Co.，Ltd

　8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.，Ltd

　8.13 Beijing Yingu Century Pharmaceutical Co.，Ltd （Beijing Shiqiao Bio-Pharmaceutical Co.，Ltd）

　8.14 Hainan Shuangcheng Pharmaceuticals Co.，Ltd

　8.15 Livzon Pharmaceuticals Co.，Ltd （Livzon：000513）

　8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.，Ltd

　8.17 Chengdu Tiantaishan Pharmaceutical Co.，Ltd

　8.18 Beijing Shuanglu Pharmaceutical Co.，Ltd

　8.19 Yangzijiang Pharmaceutical Co.，Ltd

　8.20 Changzhou Siyao Pharmaceutical Co.，Ltd

　9.1 Upstream Raw Materials Price Analysis and Influence

　9.1 Upstream Equipments Market Analysis and Influence

　9.3 Downstream Demand Analysis and Influence

　9.4 Industry Policy Analysis and Influence

　10.1 Synthesis Polypeptide Drug Marketing Channels Status

　10.2 Synthesis Polypeptide Drug Marketing Channels Management

　10.3 Synthesis Polypeptide Drug Marketing Channels Establishment

　10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend

　11.1 2014-2019 Synthesis Polypeptide Drug Industry Development Trend

　11.2 2014-2019 Market Potential Forecast

　11.3 2014-2019 R&D Trend

　11.4 2014-2019 Marketing Channels Change Trend

　12.1 Macroeconomic Development Countermeasures

　12.3 New Project Investment Proposal

　12.4 Marketing Channel Strategy Proposals

　12.5 Competitive Environment Strategy Proposals

　13.1 Synthesis Polypeptide Drug Project SWOT Analysis

　13.2 Synthesis Polypeptide Drug New Project Investment Feasibility Analysis